COPENHAGEN, Denmark — Cataract surgery is a low-risk, low-cost intervention that can improve the quality of life in people with dementia and may prevent progression to some extent.

Orthocell (ASX:OCC) has boosted its stake in a Western Australia-based biotech company called ‘PearlBone,’ which uses nacre, the material from which pearls are made, but which also includes part of ...